
Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Specifically, we partner with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.
At Xontogeny, we believe that scientific founders supply the passion and determination integral to the success of their companies. While the foundation of success is good science, how that science is developed from inception to maturity serves as the critical pathway. Therefore, we focus on supporting the entrepreneur’s pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. With our team’s track record of success, entrepreneurs of affiliated companies will gain the support and guidance they need while remaining lean, virtual, and without the financial burden of supporting a full-time team.
This dynamic model has the additional benefit of supporting the goals of the founding scientists and entrepreneurs to retain more control and equity, while increasing the chance of accessing investment, and ultimately development success.
Location: United States, Massachusetts, Boston
Employees: 11-50
Founded date: 2016
Investment Type: Accelerator
Investment Stage: Series A
Portfolio 23
Date | Name | Website | Total Raised | Location |
02.11.2022 | LianBio | lianbio.co... | $635M | China, Sha... |
02.11.2022 | Juno Bio | junodx.com | - | United Sta... |
02.11.2022 | VivoSense | vivosense.... | $25M | United Sta... |
02.11.2022 | PolyCore T... | polycoreth... | - | - |
02.11.2022 | avengebio | avengebio.... | $45M | United Sta... |
02.11.2022 | Zucara | zucara.ca | $25.25M | - |
02.11.2022 | SURF BIO | surf.bio | $16M | - |
02.11.2022 | AsclepiX T... | asclepix.c... | $50M | United Sta... |
02.11.2022 | CereVasc e... | cerevasc.c... | $44M | United Sta... |
02.11.2022 | AAVANTIBIO | aavantibio... | $107M | United Sta... |
Show more
Persons 9
Date | First Name | Last Name | Title | Location | |||
- | Fred | Callori | - | linkedin.c... | - | f**d@xonto... | - |
- | Ben | Askew | Partner, R... | linkedin.c... | - | b*n@xontog... | - |
- | Takeru | Furuya | Senior Ass... | linkedin.c... | - | t****u@xon... | - |
- | Chris | Garabedian | Chairman a... | linkedin.c... | - | c***s@xont... | - |
- | Shobha | Parthasara... | - | linkedin.c... | - | s****a@xon... | - |
- | Thien | Nguyen | Associate | linkedin.c... | - | t***n@xont... | - |
- | Aaron | Goldman | - | linkedin.c... | - | a******n@x... | - |
- | Gianna | Hoffman-Lu... | Partner | linkedin.c... | - | g****a@xon... | - |
- | Wendy | Cort | Director o... | linkedin.c... | - | i**o@xonto... | - |
Mentions in press and media 24
Date | Title | Description | Source |
03.04.2024 | Addex spin-off launched with USD63 million investment | Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio ... | startuptic... |
25.03.2024 | AbbVie Gets Another Ulcerative Colitis Contender via $137M L... | AbbVie already has blockbuster drugs for ulcerative colitis, but that isn’t stopping the pharmaceuti... | medcitynew... |
20.01.2022 | Investors disagree on whether digital health is in a bubble ... | If there were any doubts that digital health funding, especially in the U.S., is on a rocket ride st... | medcitynew... |
08.09.2021 | University of Washington spinout A-Alpha Bio snags $20M for ... | A-Alpha Bio founders David Younger (standing) and Randolph Lopez. (A-Alpha Bio Photo). A-Alpha Bio w... | geekwire.c... |
08.09.2021 | A-Alpha Bio Secures $20M Series A Financing to Accelerate Dr... | When it comes to measuring protein-protein interactions and assisting pharma in the discovery of ant... | prweb.com/... |
13.05.2021 | Perceptive Advisors Closes $515M Early-Stage Biotech Fund | What You Should Know: – Perceptive Advisors and biotech accelerator Xontogeny, focused on seed inves... | hitconsult... |
12.05.2021 | Perceptive Advisors unveils $515M fund, its 2nd for early-st... | After 20 years of backing clinical-stage biotechs, Perceptive Advisors took a leap in 2019, teaming ... | fiercebiot... |
12.05.2021 | Juno Diagnostics : Announces Closing of $25 Million Series A... | Juno Diagnostics (JunoDx), a company focused on improving access to vital genetic health information... | marketscre... |
12.05.2021 | Perceptive Advisors unveils $515M fund, its 2nd for early-st... | After 20 years of backing clinical-stage biotechs, Perceptive Advisors took a leap in 2019, teaming ... | fiercebiot... |
12.05.2021 | Juno Diagnostics Announces Closing of $25 Million Series A F... | Join Transform 2021 this July 12-16. Register for the AI event of the year. – Reproductive health pi... | venturebea... |
Show more